During the past decade, Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 16 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 13 clinical trials were completed. i.e. 433.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" #1 sponsor was "Celgene" with 7 trials, followed by "Shire" with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (7 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (2 trials) and "Acute Bacterial Skin and Skin Structure Infections" (1 trials). Many other conditions were trialed in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" in a lesser frequency.

Most popular intervention types in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" are "Drug" (24 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials), "Filgotinib" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".